Overexpression of the ErbB family is prevalent in the pathogenesis of a variety of cancers, including head and neck, breast, lung, gastrointestinal tract, prostate, gynecologic tract, and pancreas, and improper ErbB signalling increases resistance to traditional therapeutic modalities such as hormonal agents, chemotherapy, and radiotherapy.176. Here, EGFR is linked to cancer.